ArticleMedical oncology (Northwood, London, England)2020

The DPP-IV inhibitor saxagliptin promotes the migration and invasion of papillary thyroid carcinoma cells via the NRF2/HO1 pathway.

Liang He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.